- Sort by Relevance
- Display 15 Products per page
Published: September 1, 2006 | Price: $1,200.00 – $5,990.00
This volume of the Medical Imaging Markets series explores the world of magnetic resonance imaging (MRI). This modality continues to generate growth as applications expand and new "open" systems penetrate the market. This report provides market data through 2010 including: revenue forecasts unit sales installed base procedure volumes Geographic analysis include dollar volume and unit sales forecasts: Worldwide North America Europe Asia & Latin America China & Emerging Economies The report includes information about MR types, technical challenges, application-specific sales,...Published: September 1, 2006 | Price: $1,995.00 – $7,800.00
This comprehensive evaluation of the blood industry provides an analysis of all the key market segments involved in this industry, including blood products such as: Red Blood Cells (RBCs) Immunoglobulins Albumin Other Plasma Products Synthetic HBOC and PFC Agents Recombinant Factors And blood supply management products, including: Blood Collection Equipment Automated Blood Collection Equipment Blood Banking and Plasmapheresis Testing Blood Typing Human Immunodeficiency Virus (HIV) Testing Hepatitis A Virus Testing Hepatitis B Virus Testing Hepatitis C Virus Testing Human T-Cell...Published: July 1, 2006 | Price: $995.00 – $7,000.00
This report provides and in-depth analysis of the market for prescription drugs used in the treatment of gastrointestinal (GI) disorders, such as nausea and vomiting, heartburn, gastro-esophageal reflux disease (GERD), ulcer, cancers of the GI tract (colorectal, esophageal, and gastric), Crohn’s disease, ulcerative colitis, irritable bowel syndrome (IBS), diverticular disease, constipation, celiac disease, short bowel syndrome, diarrhea, intestinal obstruction, and digestive enzyme disorders. For each major segment, the analysis provides an overview of the diseases including epidemiology, a detailed description...Published: July 1, 2006 | Price: $2,995.00 – $7,800.00
Ophthalmology is entering one of the most remarkable phases in recent history of this industry; new technologies and treatment modalities for both visual acuity and major eye diseases may dramatically change the composition and competitive dynamics of this market. As RK and LASIK changed the market a few years ago, even newer competitive technologies are just now emerging. From the advent of photodynamic therapy and new drug delivery techniques to revolutionary surgical approaches to refractive vision correction, ophthalmology is poised...Published: June 1, 2006 | Price: $995.00 – $7,800.00
The protein therapeutics sector is a story of triumphant science, representing both life-saving treatments for millions and a multi-billion dollar industry. This report details both the scientific and business aspects of the protein therapeutics marketplace, including market size and growth, competitive market share, geographical segmentation, top products, and forecasts to 2010 for each of the following individual product areas: Monoclonal Antibodies Erythropoietins Insulin Interferons Growth Factors Interleukins Blood Clotting Factors Tissue Plasminogen Activator Human Growth Hormones Reproductive Hormones Recombinant BMP-2...Published: June 1, 2006 | Price: $995.00 – $5,990.00
This report focuses on the specific needs and market applications of the critical care pharmaceuticals market, the options presented by the market, the factors associated with strategic market development, and prospects for the future. The major indications for critical care are discussed as well as the range of pharmaceutical products used in the critical care environment. The strategic market characteristics of the critical care pharmaceuticals market are also discussed. The trends —- cost-containment programs, restricted formulary acceptance, clinical pharmacy, and...Published: June 1, 2006 | Price: $995.00 – $7,000.00
Despite troublesome safety problems with past entrants into this market, the veritable epidemic of overweight and obesity continues to make this sector an extremely attractive target for pharmaceutical developers. This new title provides a considered view of the market for medical interventions in the battle against obesity, including U.S. and worldwide market size and growth forecasts, competitive market share and extensive pharmaceutical pipeline information. The report discusses both prescription and OTC drug markets and surgical interventions. Market size and growth...Published: May 1, 2006 | Price: $3,500.00 – $7,000.00
The commercial world of medical sensors is vibrant and evolving rapidly. Reports that are only a year or two old are already out-of-date as new technologies make rapid penetration. This new edition attacks the field from the point of view of current R&D, technology and innovation, with an eye to potential markets and emerging technologies in clinical medicine, remote and military applications, process and materials quality control, environmental monitoring, and food and drug quality control. Technology trends and particulary significant...Published: May 1, 2006 | Price: $3,550.00 – $7,000.00
This complete re-evaluation of the Men’s Health market focuses on the following prescription drug treatment segments: Men’s Cancer Men’s Sexual Dysfunction Men’s Sexually Transmitted Diseases Men’s Urinary Conditions Andropause The report covers drugs used for the treatment of prostate cancer, testicular cancer, impotence, premature ejaculation, and benign prostatic hyperplasia (BPH), urinary incontinence, and STD’s such as HIV, herpes, and genital warts. For each segment, revenues and forecasts are made by type of drug through 2010; competitive market share of the...Published: May 1, 2006 | Price: $3,500.00 – $7,000.00
CRO is a need-to know practice in pharmaceutical marketing today; but information is not always easy to find. This second edition of Kalorama’s best-selling look at the clinical contract research industry provides the key information competitors need to navigate the complexities and costs of clinical research in the drug development process. In addition to a comprehensive discussion of the market and regulatory environment, the report details: the size and nature of the drug research pipeline, the size and growth of...Published: April 1, 2006 | Price: $3,900.00 – $7,800.00
This completely updated edition of Kalorama’s comprehensive and indispensable report covers the breadth of traditional IVD testing. The report contains complete market statistics and analysis for all areas of IVD, including: Point-of-Care Clinical Chemistry Immunoassays Molecular Assays Hematology Coagulation Microbiology and Virology Blood Banking Histology and Cytology Market size, growth, share, and geographic distribution, as well as trends in technology development, regulatory and reimbursement issues, clinical care, and business environments are discussed. Projections are made through 2010. This new 1,000-page...Published: April 1, 2006 | Price: $3,500.00 – $7,000.00
Adjunctive therapies are not only vital to the success of cancer treatments, enhancing compliance and outcomes, but they are also a dynamic area of research and development in a variety of disciplines from drug delivery to biologics. It also happens to be the largest portion of the overall cancer therapeutics market. This report provides the reader with a comprehensive analysis of the worldwide market for therapeutics to treat and manage symptoms in cancer patients. Market information, including market size and...Published: April 1, 2006 | Price: $2,500.00 – $7,000.00
The landscape of generic companies is changing: their relative might in the industry is increasing and the product lines their offering are growing in depth and breadth. Strong growth in the sector has come not only from more aggressive tactics and better acceptance in the clinical and consumer population, but by the loss of patent protection in the past few years of some huge-name drugs, including Prozac, Zocor, Prilosec, Prevacid, Sporanox, Evista, Flovent, Claritin, Allegra, Diflucan, Zofran, Zoloft, and Pravachol....Published: March 1, 2006 | Price: $3,500.00 – $7,000.00
There are hundreds of drugs in Phase III clinical trials, of which almost 200 of them may gain market approval from the FDA in the coming 5 years. Which drugs will make it and how these drugs impact existing pharmaceutical markets in terms of overall size and competitive share is one of the most difficult forecasting projects in market research. In this nearly 500-page analysis, Kalorama Information has compiled all the relevant information about the candidates, their value, and their...Published: March 1, 2006 | Price: $3,500.00 – $7,000.00
The strategic interplay of of HIV/AIDS diagnostics and therapeutics is one of the most complex that the healthcare industry has ever seen. In order to cope with the challenges and opportunities of HIV/AIDS, companies must think on a global basis, and in addition to the basic pathology and complications of HIV/AIDS, there are societal and ethical pressures, geopolitical factors, and evolving marketplace disruptions. For the development of a coherent strategy in this therapeutic area, companies must clearly focus on three...